IDO1-PROTAC

N/A

Report date: 2022/11/24 09:31:49
NME

Base Information

Drug NameIDO1-PROTAC
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitorsNuclear factor NF-kappa-B complex inhibitors
TargetsIndoleamine 2,3-dioxygenaseNuclear factor NF-kappa-B complex
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNorthwestern University Feinberg School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesNorthwestern University Feinberg School Of Medicine
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A